Skip to content
value.today

MedAssets

MDASUnlisted company
No market cap data
Compare
World rank
—
no current market cap
Revenue
$720 M
For year ending December-2014
Net income
$-20 M
-2.8% margin
SEC filing
Employees
—

MedAssets in brief

MedAssets is an unlisted company, based in Alpharetta, USA. In the year to December 2014 it had sales of $720 M and a net loss of $20 M.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About MedAssets

MedAssets, Inc. was an American healthcare performance improvement company. It provided products and services to 4,400 hospitals and 122,000 non-acute healthcare providers.

The Alpharetta, Georgia based company had 15 offices across the United States. States with a MedAssets location included California, Colorado, Georgia, New Jersey, Texas, and Washington.

In early 2016, MedAssets was split into two companies and was sold out. The company no longer exists in its original form, although some of its products exist under other brand names under various companies including nThrive (now FinThrive).

From Wikipedia: read the full article · text available under CC BY-SA 4.0

MedAssets timeline

2 events, 2003–2007
  1. 2003
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2007
  4. 🔔
    Initial public offering
    Final prospectus filed with the SEC on 13 December 2007; shares registered for exchange trading on 10 December 2007.

Events of MedAssets from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about MedAssets

Acquisitions and changes
Taken over: the company reported a change in control and the delisting of its shares to the SEC on 27 January 2016 (Form 8-K).

Market cap history

Not enough history yet.

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
—
Price / book
—
Free cash flow yield
—
Net margin (TTM)
-2.8%
Operating margin
6.5%
Return on equity
-4.6%
Liabilities / assets
74.0%
Net debt
$839M
Revenue growth
+5.9%
R&D / revenue
4.3%

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2009: revenue $341M, net income $20M$341MFY09Fiscal year ending Dec 2010: revenue $391M, net income $-32M$391MFY10Fiscal year ending Dec 2011: revenue $578M, net income $-15M$578MFY11Fiscal year ending Dec 2012: revenue $640M, net income $-7M$640MFY12Fiscal year ending Dec 2013: revenue $680M, net income $27M$680MFY13Fiscal year ending Dec 2014: revenue $720M, net income $-20M$720MFY14
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2014$720M+5.9%$46M$-20M-2.8%
Dec 2013$680M+6.3%$91M$27M4.0%
Dec 2012$640M+10.7%$85M$-7M-1.1%
Dec 2011$578M+47.8%$42M$-15M-2.7%
Dec 2010$391M+14.7%$-20M$-32M-8.2%
Dec 2009$341M—$50M$20M5.8%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2014$139M$63M$76M$-0.34—
Dec 2013$153M$59M$94M$0.45—
Dec 2012$158M$66M$91M$-0.12—
Dec 2011$124M$17M$107M$-0.27—
Dec 2010$106M$13M$93M$-0.57—
Dec 2009$60M$12M$49M$0.34—

SEC filings

Official filings of MedAssets with the US Securities and Exchange Commission.

Annual results

Revenue
$720 M
Operating income
$46 M
Net income
$-20 M

For year ending December-2014 · source: SEC filing

Balance sheet

Total assets
$1.7 B
Total liabilities
$1.3 B
Total equity
$446 M

As of December-2014

Insider trading at MedAssets#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$0
open market only
Insiders on file
32
since
MedAssets: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Rand A. BallardChief Customer Officer, DirectorDisposal to the company-116,510——0Form 4
filed Anthony Colaluca Jr.Chief Financial OfficerDisposal to the company-17,660——0Form 4
filed R. Halsey WiseChairman and CEO, DirectorDisposal to the company-299,386——0Form 4
filed C. A. PiccoloDirectorDisposal to the company-150,933——0Form 4
filed Kevin M. TwomeyDirectorDisposal to the company-4,365——0Form 4
filed Terrence J. MulliganDirectorDisposal to the companyindirect-139,570——0Form 4
filed Charles O. GarnerChief Financial OfficerDisposal to the company-79,144——0Form 4
filed Amy AmickPresident, RCM SegmentDisposal to the company-10,704——0Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: MedAssets#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Buybacks, Q3 2015
$16.5M
Q3 2015
MedAssets share buybacks by quarter
Buybacks, quarterFiscalSpent
Q3 2015Q3 2015$16.5M
Q2 2015Q2 2015$8.7M
Q1 2015Q1 2015$3.8M
Q4 2014Q4 2014$0.2M
Q3 2014Q3 2014$0.3M
Q2 2014Q2 2014$29.8M
Q1 2014Q1 2014$15.7M
Q4 2012Q4 2012$0M
Q3 2012Q3 2012$0M
Q2 2012Q2 2012$0M
Q1 2012Q1 2012$0.6M
Q4 2011Q4 2011$4.2M

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

MedAssets scorecard#

Passes 6 of the 15 checks that could be worked out: strongest in growth (3 of 5), weakest in profitability (0 of 4). Fiscal year 2014.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growth3 of 5
    • ✓Revenue grew in the newest year5.8%Revenue up 5.8% in fiscal 2014.
    • ✓Revenue up more than 5% a year over three years7.6%7.6% a year over the three years to fiscal 2014.
    • –Faster growth over three years than its peers' medianToo few peers for a median.
    • ✗Earnings per share grew in the newest year-0.34 vs 0.45Diluted EPS -0.34 in fiscal 2014 against 0.45 the year before (report's currency).
    • ✗Net income higher than five years earlier-$20 M-$20 M in fiscal 2014 against $20 M in 2009.
    • ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2014.
  • Profitability0 of 4
    • ✗Profitable in the newest year-$20 MNet income -$20 M in fiscal 2014.
    • ✗Profitable in each of the last five years1 of 5Profitable in 1 of the five years to fiscal 2014.
    • –Operating margin above its peers' medianToo few peers for a median.
    • ✗Return on equity above 15%-4.4%-4.4% in fiscal 2014.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✗Operating margin wider than three years earlier6.5%6.5% in fiscal 2014 against 7.3% in 2011.
  • Financial health1 of 4
    • ✗Short-term assets cover short-term liabilities0.7×Current ratio 0.66 at the end of fiscal 2014.
    • ✗Debt below equity1.9×Debt to equity 1.91 at the end of fiscal 2014.
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • ✗Operating income covers interest five times1.0×Operating income 1.0 times interest in fiscal 2014.
    • ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2014.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returns2 of 2
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✓Share count up no more than 2% in a year-2.2%Diluted shares down 2.2% in fiscal 2014.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • ✓Free cash flow covers dividends and buybacks$76 MFree cash flow $76 M against $46 M paid out in fiscal 2014.

Worked out from the statements as filed (sec), the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

MedAssets: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

MedAssets: statements by fiscal year
PeriodTrendFY 2014to Dec 31, 2014FY 2013to Dec 31, 2013FY 2012to Dec 31, 2012FY 2011to Dec 31, 2011FY 2010to Dec 31, 2010FY 2009to Dec 31, 2009
Income statement
Revenue720680640578391341
Cost of revenue17215213912210175
Research and development313128272019
Selling and marketing676160574745
General and administrative238232218203124111
Total costs and expenses674590555536411291
Operating income46918542−2050
Interest expense and finance costs464766712818
Other non-operating income (expense)0.30.30.73.60.70.4
Income before tax1.244−8.4−25−4633
Income tax2217−1.5−9.9−1413
Net income attributable to shareholders−2027−6.9−15−3220
Earnings per share, basic-0.340.46-0.12-0.27-0.570.36
Earnings per share, diluted-0.340.45-0.12-0.27-0.570.34
Shares, weighted average (basic)606057575655
Shares, weighted average (diluted)606157575658
Balance sheet
Cash and cash equivalents122.81463475.5r
Receivables128889610410068
Other current assets3124221820—
Current assets17611914320118596
Property, plant and equipment1701581341017855
Goodwill1,0581,0281,0281,0281,036512
Other intangible assets27626733040348496
Total assets1,7191,6141,6781,7951,845779
Accounts payable27242521188.7
Debt due within a year3016166.4r−6.4—
Current liabilities26721722531828399
Long-term debt851749870897954—
Total liabilities1,2721,1241,2451,3761,410341
Retained earnings−248−228−255−249−233−201
Shareholders' equity446490434419436437
Total liabilities and equity1,7191,6141,6781,7951,845779
Shares outstanding606259585857
Cash-flow statement
Share-based compensation1814105.01117
Cash from operating activities13915315812410660
Capital expenditure−63−59r−66r−17−13−12
Acquisitions, net of cash acquired−141———−749−18
Cash from investing activities−205−59−66−49−780−46
Shares issued3.6107.72.01110
Shares bought back−46—−0.6−5.0——
Cash from financing activities75−105−141−59715−14
Change in cash9.3−11−4916410.1
Report10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2015. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Events at MedAssets#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Impairment 1 · Restructuring 1 · Taken over and delisted 1 · Change in control 1 · Acquisition or sale completed 2 · Directors and officers 9 · Material agreement 3 · Agreement ended 1 · New debt 2 · Shareholder rights changed 1 · Bylaws or fiscal year changed 2 · Shareholder vote 3 · Results announced 8

MedAssets: events reported to the SEC
FiledWhat happenedFiling
Taken over and delistedChange in controlAcquisition or sale completedMaterial agreementAgreement endedNew debtShareholder rights changedBylaws or fiscal year changed8-K
Shareholder vote8-K
Results announced8-K
Material agreementBylaws or fiscal year changed8-K
ImpairmentRestructuring8-K
Directors and officers8-K
Results announced8-K
Directors and officers8-K
Shareholder vote8-K
Results announced8-K
Directors and officers8-K
Directors and officers8-K
Directors and officers8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Directors and officers8-K
Results announced8-K
Acquisition or sale completed8-K
New debt8-K
Material agreement8-K
Results announced8-K
Shareholder vote8-K
Directors and officers8-K
Directors and officers8-K
Results announced8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Jan 27, 2016

Layoffs at MedAssets#

From US state WARN notices and SEC 8-K restructuring filings, newest first.

People, last 12 months
0
0 notices and filings
People, all years
180
2015–2015
Latest
180 people
2015-09-28
MedAssets: people laid off by year and month
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2015········180···180
MedAssets: latest layoffs
AnnouncedPeopleKindWhereSource
180 people (5% of workforce)Restructuring planSEC 8-K“As part of this cost reduction program, the Company plans to reduce its workforce by approximately 180 full-time employees, or about 5% of its total headcount by year-end 2015.”Filing

Source: State WARN notices and SEC 8-K item 2.05

Questions, comparisons and similar companies#

Sources and freshness

Annual results:
For year ending December-2014
Balance sheet:
As of December-2014
Profile updated:
Nov 16, 2026

Figures from SEC filing, Wikidata, Wikipedia, value.today research; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at MedAssets? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show MedAssets's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about MedAssets? Suggest a correction